Syngen Biotech Co

Syngen Biotech Co EBIT Margin

The EBIT Margin (Operating Margin) of Syngen Biotech Co (8279.TWO) as of Nov 4, 2026 is 15.83 %. In the previous year, EBIT Margin (Operating Margin) was 15.41 % — a change of 2.72% (higher).

EBIT Margin

15.83 %

YoY

2.72%

Last updated:

EBIT Margin (Operating Margin) of Syngen Biotech Co is 2025 15.83 % . EBIT Margin (Operating Margin) of Syngen Biotech Co was 2024 15.41 % . It decreases by 2.72% higher compared to the previous year.

Syngen Biotech Co's operating (EBIT) margin stands at 15.8%, down from 20.3% several years earlier.

The Syngen Biotech Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
15.38 TWD
Jan 1, 2019
18.72 TWD
Jan 1, 2020
19.77 TWD
Jan 1, 2021
20.28 TWD
Jan 1, 2022
20.76 TWD
Jan 1, 2023
18.57 TWD
Jan 1, 2024
15.41 TWD
Jan 1, 2025
15.83 TWD
The Syngen Biotech Co EBIT Margin history
YEAREBIT MarginYoY
15.83 %+2.72%
15.41 %-17.05%
18.57 %-10.55%
20.76 %+2.39%
20.28 %+2.59%
19.77 %+5.59%
18.72 %+21.76%
15.38 %-14.82%
18.05 %+19.99%
15.05 %+17.18%
12.84 %+77.73%
7.22 %-65,347.14%
-0.01 %-118.34%
0.06 %-60.13%
0.15 %-118.77%
-0.81 %-49.46%
-1.60 %-38.53%
-2.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syngen Biotech Co Stock analysis

What does Syngen Biotech Co do? Syngen Biotech Co., Ltd. generates revenue through the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. The company's portfolio includes active pharmaceutical ingredients, health food raw materials, and animal health products. Additionally, the firm offers medical equipment such as bone density analyzers, blood glucose analyzers, and biochemical analyzers to its customer base. Syngen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngen Biotech Co stock

EBIT Margin (Operating Margin) of Syngen Biotech Co is 15.83 % in 2025.

EBIT Margin (Operating Margin) of Syngen Biotech Co changed from 15.41 % to 15.83 %, representing a 2.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Syngen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Syngen Biotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Syngen Biotech Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Syngen Biotech Co